Items Per Page 102550 Year All2024202320222021202020192018201720162015201420132012201120102009 February 22, 2024 Delcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System) PDF Version February 16, 2024 Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version January 31, 2024 Delcath Systems Receives Permanent J-Code (J9248) for HEPZATO™ (melphalan/Hepatic Delivery System) Effective April 1, 2024 PDF Version January 23, 2024 Delcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference PDF Version January 16, 2024 Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT™ PDF Version January 12, 2024 Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version
February 22, 2024 Delcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System) PDF Version
February 16, 2024 Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version
January 31, 2024 Delcath Systems Receives Permanent J-Code (J9248) for HEPZATO™ (melphalan/Hepatic Delivery System) Effective April 1, 2024 PDF Version
January 23, 2024 Delcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference PDF Version
January 16, 2024 Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT™ PDF Version
January 12, 2024 Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version
